2023
DOI: 10.3389/fmicb.2023.1113021
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial effector kinases and strategies to identify their target host substrates

Abstract: Post-translational modifications (PTMs) are critical in regulating protein function by altering chemical characteristics of proteins. Phosphorylation is an integral PTM, catalyzed by kinases and reversibly removed by phosphatases, that modulates many cellular processes in response to stimuli in all living organisms. Consequently, bacterial pathogens have evolved to secrete effectors capable of manipulating host phosphorylation pathways as a common infection strategy. Given the importance of protein phosphoryla… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 104 publications
0
1
0
Order By: Relevance
“…XopC2 hijacks MeHSP90.9 to inhibit its phosphorylation by MeCPK1 and transcriptional activation of downstream genes Considering that MeHSP90.9 acts as a positive regulator against Xam (Wei et al, 2021a,b), we speculated whether MeHSP90.9 targets Xam proteins during cassava-Xam interaction. To elucidate this possibility, Y2H assay screening and further DNAsequencing identified effector XopC2, a non-TAL type III effector (Qin et al, 2018;St Louis et al, 2023), as a MeHSP90.9 candidate interacting protein. This protein interaction was further verified in vivo and in vitro using Y2H, BiFC and pull-down assays (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…XopC2 hijacks MeHSP90.9 to inhibit its phosphorylation by MeCPK1 and transcriptional activation of downstream genes Considering that MeHSP90.9 acts as a positive regulator against Xam (Wei et al, 2021a,b), we speculated whether MeHSP90.9 targets Xam proteins during cassava-Xam interaction. To elucidate this possibility, Y2H assay screening and further DNAsequencing identified effector XopC2, a non-TAL type III effector (Qin et al, 2018;St Louis et al, 2023), as a MeHSP90.9 candidate interacting protein. This protein interaction was further verified in vivo and in vitro using Y2H, BiFC and pull-down assays (Fig.…”
Section: Resultsmentioning
confidence: 99%